ABOUT ADVOG M 0.2
ADVOG M 0.2+ TABLET is a combination of Metformin and Voglibose which belongs to the group of medicines called Antidiabetic agents. ADVOG M 0.2+ TABLET is indicated as a second-line therapy for the management of type II diabetes mellitus when diet, exercise and therapy with single agents does not result in adequate glycemic control. Type II diabetes is a chronic medical condition in which the body does not make enough insulin, or the produced insulin does not work well. Symptoms include excessive urination, excessive thirst, hunger, fatigue and blurred vision. Along management with ADVOG M 0.2+ TABLET, follow regular exercise and diet plan as advised by your doctor to achieve better results.  Prior and during therapy with ADVOG M 0.2+ TABLET, your doctor might access your kidney functions frequently to avoid the risk of side effects, especially if you are elderly with poor kidney functions. Avoid consumption of alcohol while taking ADVOG M 0.2+ TABLET as it could aggravate your existing disease condition and increase the risk of lactic acidosis. ADVOG M 0.2+ TABLET is generally not recommended for use in pregnant or breastfeeding women and in children (aged less than 18 years) due to lack of safety and effectiveness. It should be used with caution in elderly patients (aged 65 years or above). The most common side effects of taking ADVOG M 0.2+ TABLET are nausea, vomiting, diarrhea, stomach pain, headache and dizziness. Consult your doctor if any of the side effects worsen.